METTL3 and cancer: While lactylation of the catalytic subunit METTL3 has been reported to enhance m6A deposition in cancer immunity,24 our study unveils a distinct regulatory mechanism centered on the regulatory subunit WTAP in the context of infection-driven MASLD.